Last updated on April 2019

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)


Brief description of study

An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Detailed Study Description

Primary

To evaluate the long-term safety and tolerability of seladelpar

Secondary

To evaluate the long-term efficacy of seladelpar

Clinical Study Identifier: NCT03301506

Find a site near you

Start Over

Universitatsklinikum Erlangen

Erlangen, Germany
8.68miles
  Connect »